Lapatinib

Related products

• 

  Breast cancer , Renal cell carcinoma (RCC)

  Sorafenib

  【Product name】NEXAVAR

  [English common name]Sorafenib

  [Chinese common name]Sorafenib

  [English name]

  [Chinese other name]Solafini, sorafini monomer

  [indications]
  Sorafenib: TYKERB lapatinib is used in combination with capecitabine to treat ErbB-2 overexpression and has previously received advanced or metastatic treatments including anthracyclines, paclitaxel, and trastuzumab (Herceptin). SexBreast cancer.
  Sorafenib tosylate tablets: treatment of advanced surgeryRenal cell carcinoma.
  Nexavar (Sorafenib): Sorafenib has been approved for the treatment of advanced renal cell carcinoma (the most common type of kidney cancer). In addition, there are currently nearly 50 clinical trials in the world that use sorafenib to treat a variety of other cancers.

  【Dosage】
  Sorafenib: The recommended dose is 1250 mg, once a day, on days 1 to 21, with capecitabine 2000 mg/d, and on the first to 14 days in 2 divided doses. Lapatinib should be taken once a day. It is not recommended to take it in divided doses. Take 1 h before meals or 2 h after meals. If one dose is missed, the dose will not be doubled on the second day. Pregnancy level D, pregnant women are banned. It is unclear whether milk secretion is passed, and lactating women should stop breastfeeding. There were no significant differences between the elderly and young patients. Patients with severe kidney damage and dialysis have not been clinically tested, and patients with moderate to severe liver damage should be given a dose reduction.
  Sorafenib tosylate tablets:
  Recommended Dosage: It is recommended to take sorafenib for 0.4 g (2 x 0.2 g) each time, twice daily, on an empty stomach or with a low-fat, medium-fat diet.
  How to use: Oral, swallow with a cup of warm water.
  Treatment time: The treatment should be continued until the patient is unable to clinically benefit or tolerate the toxic reaction.
  Nexavar (Sorafenib): Patients should read the product instructions and patient instructions carefully before taking the drug. Patients should be advised to take effective contraception during the medication and to try to conceive after at least 2 weeks of discontinuation. Inform patients to take the medicine on an empty stomach. If the patient forgets to take the medicine, there is no need to increase the dose for the next dose. When the patient has a rash on the hands and feet during the medication, he should contact the doctor for treatment accordingly.

  [Storage]
  Sorafenib tosylate tablets: Store at a temperature below 25 ° C. Keep the drug out of the reach of children.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer

  Pabotini

  【Product name】Ibrance

  [English common name]Palbociclib

  [Chinese common name]Pabotini

  [English name]

  [Chinese other name]

  [indications]Pabosini is a combination of estrogen receptor (ER) positive in women with postmenopausal women treated with letrozole, and negative for human epidermal growth factor receptor 2 (HER2)Breast cancerAs an initial endocrine-based treatment for kinase inhibitors in the treatment of metastatic disease.

  [Usage and Dosage] In combination with endocrine therapy, 125 mg is usually administered orally once a day to an adult as a parvociclib for 3 weeks, followed by withdrawal for 1 week. Repeat management with this loop. In addition, the weight is reduced according to the condition of the patient.

  [Storage] The drug does not require any special storage conditions.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer

  Eriblin mesylate

  【Product name】Halaven

  [English common name]Eribulin

  [Chinese common name]Eriblin mesylate

  [English name]Eribulin Mesilate

  [Chinese other name]Erebrin mesylate

  [Indications] for the treatment of metastasis that has been treated with at least 2 chemotherapy regimensBreast cancerPatients, and the chemotherapy regimen should include an anthracycline or a taxane.

  【Dosage】Eribulin mesylate was dissolved in a 5% by volume aqueous solution of ethanol at a concentration of 0.5 g/mL, usually at a dose of 21 days (1 day): 1.4 mg at 1 d and 8 d M2, intravenous injection lasted 2-5 min.

  [Storage] From a microbiological point of view, the product should be used immediately unless the opening method eliminates the risk of microbial contamination. If not used immediately, the storage time and conditions in use are the responsibility of the user.
  If HALAVEN is not used immediately as an undiluted solution in a syringe, it should not be stored for more than 4 hours at 25 ° C and ambient light, or 24 hours at 2 ° C – 8 ° C.
  A diluted solution of HALAVEN (0.018 mg / ml to 0.18 mg / ml eribulin in sodium chloride 9 mg / ml (0.9%)) should not be stored at 2 ° C – 8 ° C for more than 24 hours unless Dilution is carried out under controlled and effective aseptic conditions.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer

  Pabista

  【Product name】Farydak

  [English common name]Panobinostat

  [Chinese common name]Pabista

  [English name]LBH-589

  [Chinese other name]

  [Indications] Farydak is combined with bortezomib and dexamethasone for the treatment of relapse and / or refractoryMultiple myelomaAdult patients who have received at least two treatment regimens, including bortezomib and immunomodulators.

  [Usage and Dosage] 20mg orally, once a day, three times a week, two weeks off each cycle for one week.

  [Storage] Do not store above 30 °C. Store in original packaging to protect it from moisture.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.